GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
24 Jul 2020 01:16 PM
RNS
GSK receives positive CHMP opinion for Belamaf
20 Jul 2020 07:00 AM
RNS
GSK and CureVac enter collaboration
15 Jul 2020 09:31 AM
RNS
Director/PDMR Shareholding
15 Jul 2020 07:00 AM
RNS
FDA Panel Votes IN FAVOR of Belantamab mafodotin
14 Jul 2020 01:19 PM
RNS
Director/PDMR Shareholding
13 Jul 2020 05:42 PM
RNS
Director/PDMR Shareholding
10 Jul 2020 04:41 PM
RNS
Director/PDMR Shareholding
10 Jul 2020 03:15 PM
RNS
Director/PDMR Shareholding
10 Jul 2020 03:07 PM
RNS
Director/PDMR Shareholding
01 Jul 2020 12:25 PM
RNS
Total Voting Rights
29 Jun 2020 08:00 AM
RNS
GSK's daprodustat gains first regulatory approval
19 Jun 2020 03:22 PM
RNS
FDA Advisory Committee review belantamab mafodotin
18 Jun 2020 12:25 PM
RNS
Director/PDMR Shareholding
16 Jun 2020 12:51 PM
RNS
Director/PDMR Shareholding
11 Jun 2020 03:56 PM
RNS
Director/PDMR Shareholding
09 Jun 2020 02:16 PM
RNS
Director/PDMR Shareholding
01 Jun 2020 12:14 PM
RNS
Total Voting Rights
29 May 2020 04:41 PM
RNS
Second Price Monitoring Extn
29 May 2020 04:37 PM
RNS
Price Monitoring Extension
26 May 2020 11:53 AM
RNS
Block listing Interim Review
19 May 2020 05:51 PM
RNS
Holding(s) in Company
18 May 2020 07:09 AM
RNS
ViiV PrEP jab shows high efficacy over daily pill
13 May 2020 05:04 PM
RNS
Director/PDMR Shareholding
11 May 2020 06:07 PM
RNS
Director/PDMR Shareholding
07 May 2020 03:52 PM
RNS
Director/PDMR Shareholding
07 May 2020 07:56 AM
RNS
GSK sells its holding in Hindustan Unilever
06 May 2020 05:40 PM
RNS
Result of AGM
04 May 2020 06:00 PM
RNS
Director/PDMR Shareholding
04 May 2020 05:40 PM
RNS
Publication of a Prospectus
04 May 2020 04:18 PM
RNS
Rights attached to ordinary shares
01 May 2020 03:45 PM
RNS
Total Voting Rights
30 Apr 2020 07:00 AM
RNS
GSK's Zejula approved in first-line ovarian cancer
29 Apr 2020 12:00 PM
RNS
1st Quarter Results
29 Apr 2020 11:00 AM
RNS
Arrangements for Shareholder Webcast
16 Apr 2020 03:25 PM
RNS
Director/PDMR Shareholding
16 Apr 2020 02:21 PM
RNS
Director/PDMR Shareholding
16 Apr 2020 01:49 PM
RNS
Director/PDMR Shareholding
14 Apr 2020 04:35 PM
RNS
Director/PDMR Shareholding
14 Apr 2020 04:31 PM
RNS
Director/PDMR Shareholding
14 Apr 2020 03:09 PM
RNS
Director/PDMR Shareholding
14 Apr 2020 12:00 PM
RNS
Sanofi and GSK collaboration to fight COVID-19
09 Apr 2020 11:52 AM
RNS
AGM - Change of Arrangements
06 Apr 2020 01:00 PM
RNS
GSK and Vir Biotechnology enter collaboration
01 Apr 2020 12:57 PM
RNS
GSK completes divestment of Horlicks
01 Apr 2020 11:11 AM
RNS
Total Voting Rights
30 Mar 2020 04:06 PM
RNS
Consumer Healthcare product sales category changes
25 Mar 2020 04:42 PM
RNS
Second Price Monitoring Extn
25 Mar 2020 04:37 PM
RNS
Price Monitoring Extension
24 Mar 2020 04:40 PM
RNS
Second Price Monitoring Extn
24 Mar 2020 04:35 PM
RNS
Price Monitoring Extension

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings